1. Home
  2. MYFW vs XBIT Comparison

MYFW vs XBIT Comparison

Compare MYFW & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MYFW

First Western Financial Inc.

N/A

Current Price

$29.74

Market Cap

312.1M

Sector

Finance

ML Signal

N/A

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$2.20

Market Cap

66.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYFW
XBIT
Founded
2002
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
312.1M
66.8M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
MYFW
XBIT
Price
$29.74
$2.20
Analyst Decision
Hold
Analyst Count
3
0
Target Price
★ $33.00
N/A
AVG Volume (30 Days)
35.4K
★ 36.5K
Earning Date
10-22-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 54.02
N/A
EPS
★ 1.20
N/A
Revenue
★ $96,914,000.00
N/A
Revenue This Year
$12.88
N/A
Revenue Next Year
$8.10
$30.47
P/E Ratio
$25.23
★ N/A
Revenue Growth
★ 7.60
N/A
52 Week Low
$22.00
$2.09
52 Week High
$34.36
$3.44

Technical Indicators

Market Signals
Indicator
MYFW
XBIT
Relative Strength Index (RSI) 32.30 47.52
Support Level $27.71 $2.16
Resistance Level $30.00 $2.48
Average True Range (ATR) 0.59 0.04
MACD -0.09 0.01
Stochastic Oscillator 0.00 66.67

Price Performance

Historical Comparison
MYFW
XBIT

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: